{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:52:22Z","timestamp":1784555542551,"version":"3.55.0"},"reference-count":0,"publisher":"Physicians Postgraduate Press, Inc","issue":"08","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Psychiatry"],"published-print":{"date-parts":[[2012,8,15]]},"DOI":"10.4088\/jcp.09m05807","type":"journal-article","created":{"date-parts":[[2012,8,22]],"date-time":"2012-08-22T14:29:43Z","timestamp":1345645783000},"page":"e1056-e1061","source":"Crossref","is-referenced-by-count":16,"title":["Risk-Taking Propensity as a Predictor of Induction Onto Naltrexone Treatment for Opioid Dependence"],"prefix":"10.4088","volume":"73","author":[{"given":"Will M.","family":"Aklin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Geoffrey","family":"Severtson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Umbricht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fingerhood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George E.","family":"Bigelow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. W.","family":"Lejuez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2558","container-title":["The Journal of Clinical Psychiatry"],"original-title":[],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T12:39:10Z","timestamp":1698755950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.psychiatrist.com\/jcp\/risk-taking-propensity-predictor-induction-onto-naltrexone"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,15]]},"references-count":0,"journal-issue":{"issue":"08","published-print":{"date-parts":[[2012,8,15]]}},"URL":"https:\/\/doi.org\/10.4088\/jcp.09m05807","relation":{},"ISSN":["0160-6689"],"issn-type":[{"value":"0160-6689","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8,15]]}}}